Back
Eagle Bancorp Montana, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
74
EBMT
Eagle Bancorp Montana, Inc.
Last Price:
$19.68
Seasonality Move:
2.12%
Sell
36
NVO
Novo Nordisk A/S
Last Price:
$51.66
Seasonality Move:
4.04%
Buy
74
Eagle Bancorp Montana, Inc. (EBMT)
is a Buy
Is Eagle Bancorp Montana, Inc. a Buy, Sell or Hold?
-
The current Eagle Bancorp Montana, Inc. [EBMT] share price is $19.62. The Score for EBMT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
EBMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $51.61. The Score for NVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EBMT Stock Price Chart
What is Eagle Bancorp Montana, Inc.'s stock price today?
-
The Eagle Bancorp Montana, Inc. share price today is $19.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBMT is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $51.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
EBMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 77.58 | Buy |
| Chaikin Money Flow: | -31473 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.36 - 19.06) | Buy |
| Bollinger Bands (100): | (16.23 - 17.97) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 60.1 | Buy |
| Chaikin Money Flow: | -31905611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.86 - 49.64) | Buy |
| Bollinger Bands (100): | (48.21 - 56.95) | Sell |
EBMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.43 | Buy |
| 20-day SMA: | 18.09 | Buy |
| 50-day SMA: | 17.17 | Buy |
| 200-day SMA: | 16.97 | Buy |
| 8-day EMA: | 19.34 | Buy |
| 20-day EMA: | 18.44 | Buy |
| 50-day EMA: | 17.6 | Buy |
| 200-day EMA: | 16.88 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.09 | Buy |
| 20-day SMA: | 48.48 | Buy |
| 50-day SMA: | 49.71 | Buy |
| 200-day SMA: | 60.54 | Sell |
| 8-day EMA: | 49.07 | Buy |
| 20-day EMA: | 48.78 | Buy |
| 50-day EMA: | 50.2 | Buy |
| 200-day EMA: | 62.83 | Sell |
Eagle Bancorp Montana, Inc. Earnings Growth & EBMT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.20 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and a decrease next year of $0.17 per share.
Eagle Bancorp Montana, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||